Evaluation of Catheter Placement for Renal Replacement Therapy in Patients With Acute Kidney Injury
1 other identifier
observational
150
1 country
1
Brief Summary
The purpose of this study is to examine the placement, timing, associated complications, efficacy of temporary and tunneled catheters for renal replacement therapy in patient with acute kidney injury.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2013
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedFirst Submitted
Initial submission to the registry
July 21, 2014
CompletedFirst Posted
Study publicly available on registry
July 25, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2015
CompletedJuly 21, 2015
July 1, 2015
2.4 years
July 21, 2014
July 20, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Dialysis adequacy
Adequacy will be measured using urea reduction ratio for patients on intermittent hemodialysis. For continuous renal replacement therapy, we will record the maximum blood flow rate achievable. These measurements/recordings will be made on average within 1-3 days of starting therapy.
up to 7d after starting renal replacement therapy
Secondary Outcomes (1)
blood stream infection rates
within 30d of catheter placement
Eligibility Criteria
Patients admitted to the hospital with acute kidney injury requiring renal replacement therapy
You may qualify if:
- Patients admitted to the hospital with acute kidney injury requiring renal replacement therapy
You may not qualify if:
- End stage renal disease
- Chronic kidney disease 5 progression to end stage renal disease
- Outside hospital catheter placement
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Brigham and Women's Hospital
Boston, Massachusetts, 02215, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sushrut Waikar, MD, MHS
Brigham and Women's Hospital
- STUDY DIRECTOR
Mallika L Mendu
Brigham and Women's Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
July 21, 2014
First Posted
July 25, 2014
Study Start
January 1, 2013
Primary Completion
June 1, 2015
Study Completion
June 1, 2015
Last Updated
July 21, 2015
Record last verified: 2015-07